UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
OMB APPROVAL
------------------------------
OMB NUMBER: 3235-1014
Expires: September 30 1998
Extimated average burden
hours per response.........0.5
------------------------------
- ------------
FORM 3
- ------------
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company
Act of 1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person
Jeffrey S. Silverman
777 Third Avenue
New York, NY 10022
2. Date of Event Requiring Statement (Month/Day/Year)
11/17/99
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Issuer Name and Ticker or Trading Symbol
Financial Performance Corporation
OTC Bulletin Board: FPCX
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
(X) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
(specify below)
6. If Amendment, Date of Original (Month/Day/Year)
N/A
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
Table I -- Non-Derivative Securities Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1. Title of Security |2. Amount of |3. Ownership |4. Nature of Indirect |
| Securities | Form: | Beneficial Ownership |
| Beneficially | Direct(D) or | |
| Owned | Indirect(I) | |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C>
Common Stock | 600,000 | D | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
</TABLE>
* If the Form is filed by more than one Reporting Person, see Instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly. (Over)
<PAGE>
<TABLE>
<CAPTION>
Form 3 (continued) Table II - Derivative Securitites Beneficially Owned (e.g., puts, calls, warrants, options, convertible
securities)
___________________________________________________________________________________________________________________________________
Table II -- Derivative Securitites Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Date Exer- |3.Title and Amount | |4. Conver-|5. Owner- |6. Nature of Indirect |
Security | cisable and | of Underlying | |sion or |ship | Beneficial Ownership |
| Expiration | Securities | |exercise |Form of | |
| Date(Month/ |-----------------------|---------|price of |Deriv- | |
| Day/Year) | |Amount |deri- |ative | |
| Date | Expira- | |or |vative |Security: | |
| Exer- | tion | Title |Number of|Security |Direct(D) or | |
| cisable | Date | |Shares | |Indirect(I) | |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C> <C> <C> <C> <C>
___________________________________________________________________________________________________________________________________|
Option (right to buy) | Immed. 11/17/01| Common Stock | 500,000 | .8125 | D | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Option (right to buy) | Immed. 11/17/02| Common Stock | 250,000 | $5.00 | D | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Option (right to buy) | Immed. 11/17/02| Common Stock | 500,000 | 1.3125 | D | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Option (right to buy) | Immed. 11/17/04| Common Stock |1,000,000| $.43 | D | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
</TABLE>
Explanation of Responses:
/s/ Jeffrey S. Silverman
------------------------------
SIGNATURE OF REPORTING PERSON
November 23 , 1999
-------------------------------
DATE
***Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S. C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, See Instruction 6 for procedure
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
Page 2
